Haleon (Haleon) ROCE % : 9.38% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Haleon's annualized ROCE % for the quarter that ended in Mar. 2024 was 9.38%.

Haleon ROCE % Historical Data

The historical data trend for Haleon's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon ROCE % Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

2.90

5.29

5.45

5.98

6.96

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial									8.34	7.43	7.85	4.31	9.38

Haleon ROCE % Calculation

Haleon's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	2584.81	/	( ( (42405.603 - 5322.777)	+	(43107.595 - 5873.418) )	/ 2 )
	=	2584.81	/	( (37082.826	+	37234.177)	/ 2 )
	=	2584.81	/	37158.5015
	=	6.96 %

Haleon's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	3491.74	/	( ( (43107.595 - 5873.418)	+	(0 - 0) )	/ 1 )
	=	3491.74	/	( ( 37234.177	+	0 )	/ 1 )
	=	3491.74	/	37234.177
	=	9.38 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Haleon (NYSE:HLN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Haleon ROCE % Related Terms

Thank you for viewing the detailed overview of Haleon's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon (Haleon) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN1:Mexico HLNl:UK HLN:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.